Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Santiago Reyes, M.D.
mi
from
Oklahoma City, OK
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Santiago Reyes, M.D.
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Anderson Pharmaceutical Research
mi
from
Anderson, SC
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Anderson Pharmaceutical Research
mi
from
Anderson, SC
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Medical University of South Carolina
mi
from
Charleston, SC
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Austin Children's Chest Associates
mi
from
Austin, TX
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Austin Children's Chest Associates
mi
from
Austin, TX
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
Alamo Clinical Research Associates
mi
from
San Antonio, TX
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
Alamo Clinical Research Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
University of Texas Health Science Center
mi
from
Tyler, TX
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
University of Texas Health Science Center
mi
from
Tyler, TX
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
University of Virginia Childrens
mi
from
Charlottesville, VA
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
University of Virginia Childrens
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
University of Wisconsin UW Hospital
mi
from
Madison, WI
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
University of Wisconsin UW Hospital
mi
from
Madison, WI
Click here to add this to my saved trials
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated:  8/8/2016
UMASS Memorial Medical Center
mi
from
Worcester, MA
Clearing Lungs With ENAC Inhibition in Cystic Fibrosis
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of P-1037 Solution for Inhalation in Patients With Cystic Fibrosis (CF)
Status: Enrolling
Updated: 8/8/2016
UMASS Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Telemedici ne Management of Veterans With Newly Diagnosed Obstructiv e Sleep Apnea (OSA)
Telemedici ne Management of Veterans With Newly Diagnosed Obstructiv e Sleep Apnea (OSA)
Status: Enrolling
Updated:  8/9/2016
Philadelphia VAMC
mi
from
Philadelphia, PA
Telemedici ne Management of Veterans With Newly Diagnosed Obstructiv e Sleep Apnea (OSA)
Telemedici ne Management of Veterans With Newly Diagnosed Obstructiv e Sleep Apnea (OSA)
Status: Enrolling
Updated: 8/9/2016
Philadelphia VAMC
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine
A Randomized, Single-blind, Placebo-controlled Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine in Healthy Adult Subjects
Status: Enrolling
Updated:  8/9/2016
Johnson County Clin-Trials (JCCT)
mi
from
Lenexa, KA
Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine
A Randomized, Single-blind, Placebo-controlled Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine in Healthy Adult Subjects
Status: Enrolling
Updated: 8/9/2016
Johnson County Clin-Trials (JCCT)
mi
from
Lenexa, KA
Click here to add this to my saved trials
Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation
Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation. Can We Help Diagnose Acute Rejection and Better Predict Bronchiolitis Obliterans?
Status: Enrolling
Updated:  8/18/2016
University of Chicago Medical Center
mi
from
Chicago, IL
Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation
Correlation of Lung Biopsy, BAL, and High Resolution CT Scan in Lung Transplantation. Can We Help Diagnose Acute Rejection and Better Predict Bronchiolitis Obliterans?
Status: Enrolling
Updated: 8/18/2016
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Hoover, AL
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Hoover, AL
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Fort Mohave, AZ
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Fort Mohave, AZ
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Jonesboro, AR
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Alhambra, CA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Alhambra, CA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Huntington Beach, CA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Paramount, CA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Paramount, CA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Denver, CO
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Clearwater, FL
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Clearwater, FL
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Atlanta, GA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Savannah, GA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Savannah, GA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
DeKalb, IL
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
DeKalb, IL
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Mandeville, LA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Mandeville, LA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Metairie, LA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Metairie, LA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Boston, MA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Kansas City, MO
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Kansas City, MO
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
St. Louis, MO
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Alliance, NE
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Alliance, NE
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Johnson City, NY
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Johnson City, NY
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Utica, NY
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Utica, NY
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Columbus, OH
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Dayton, OH
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Huber Heights, OH
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Huber Heights, OH
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Hershey, PA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Hershey, PA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Pittsburgh, PA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Dallas, TX
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Houston, TX
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Vienna, VA
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Vienna, VA
Click here to add this to my saved trials
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated:  9/22/2016
GSK Investigational Site
mi
from
Hato Rey,
Inhaled Albuterol Sulfate For Acute Wheezing Due To Obstructive Airways Disease In Children
A Randomized, Double-Blind, Parallel-group, Multi-Center Study of Albuterol Sulfate HFA Inhalation Aerosol Delivered Cumulatively With a Valved Holding Chamber and an Attached Facemask in Subjects Between Birth to 23 Months of Age With Acute Wheezing Due to Obstructive Airways Disease
Status: Enrolling
Updated: 9/22/2016
GSK Investigational Site
mi
from
Hato Rey,
Click here to add this to my saved trials
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/26/2016
GSK Investigational Site
mi
from
Birmingham, AL
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/26/2016
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/26/2016
GSK Investigational Site
mi
from
Jasper, AL
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/26/2016
GSK Investigational Site
mi
from
Jasper, AL
Click here to add this to my saved trials
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/26/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/26/2016
GSK Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/26/2016
GSK Investigational Site
mi
from
Tempe, AZ
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/26/2016
GSK Investigational Site
mi
from
Tempe, AZ
Click here to add this to my saved trials
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/26/2016
GSK Investigational Site
mi
from
Berkeley, CA
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/26/2016
GSK Investigational Site
mi
from
Berkeley, CA
Click here to add this to my saved trials
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/26/2016
GSK Investigational Site
mi
from
Carmichael, CA
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/26/2016
GSK Investigational Site
mi
from
Carmichael, CA
Click here to add this to my saved trials
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated:  10/26/2016
GSK Investigational Site
mi
from
Fullerton, CA
Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)
A Randomized, 24-week, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of ARIFLO® (15mg BID) in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status: Enrolling
Updated: 10/26/2016
GSK Investigational Site
mi
from
Fullerton, CA
Click here to add this to my saved trials